Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Murphy

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.
Blood|April 24, 2020
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M Voorhees, Jonathan L Kaufman, Jacob Laubach, et al.
Water Research|June 6, 2022
Longitudinal SARS-CoV-2 RNA wastewater monitoring across a range of scales correlates with total and regional COVID-19 burden in a well-defined urban populationNicole Acosta, María A Bautista, Barbara J Waddell, et al.
Nature Medicine|December 16, 2018
Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Nature Medicine|March 20, 2018
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
JAMA Neurology|September 28, 2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic ThrombocytopeniaMayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
Lancet (London, England)|June 10, 2024
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trialPeter Kelly, Robin Lemmens, Christian Weimar, et al.
Blood|April 24, 2020
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trialPeter M Voorhees, Jonathan L Kaufman, Jacob Laubach, et al.
Water Research|June 6, 2022
Longitudinal SARS-CoV-2 RNA wastewater monitoring across a range of scales correlates with total and regional COVID-19 burden in a well-defined urban populationNicole Acosta, María A Bautista, Barbara J Waddell, et al.
Nature Medicine|December 16, 2018
Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Nature Medicine|March 20, 2018
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasiteNeville K Kisalu, Azza H Idris, Connor Weidle, et al.
Annals of Neurology|June 11, 2022
Management of Cerebral Venous Thrombosis Due to Adenoviral COVID-19 VaccinationAdrian Scutelnic, Katarzyna Krzywicka, Joshua Mbroh, et al.
JAMA Neurology|September 28, 2021
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic ThrombocytopeniaMayte Sánchez van Kammen, Diana Aguiar de Sousa, Sven Poli, et al.
Pageof 21